Several Companies

 
News Articles for Several Companies top ^
2014/12/9
FIRST OF SEVERAL PHASE 3 TRIALS TO REPORT RESULTS INDIANAPOLIS , Dec.
Sign-up for Lilly and Incyte Announce Positive Top-Line Results From Phase 3 Trial of Baricitinib in Moderate to Severe Rheumatoid Arthritis investment picks
2015/1/6
Pioneer Natural Resources Company (NYSE:PXD) (“Pioneer” or “the Company”) today announced that severe winter weather in West Texas has significantly impacted production and drilling operations in the Spraberry/Wolfcamp area.
Sign-up for Pioneer Natural Resources Announces That Severe Winter Weather Has Impacted Production and Drilling Operations in West Texas investment picks
2014/12/16
Nuveen Investments, a leading global provider of investment services to institutions as well as individual investors, today announced that several closed-end funds have declared additional cash distributions with the record, ex-dividend and payable date mentioned below.
Sign-up for Several Nuveen Closed-End Funds Declare Capital Gains investment picks
2015/2/4
Pfizer Inc. (NYSE:PFE) announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the supplemental New Drug Application (sNDA) for XELJANZ ® (tofacitinib citrate) 5 mg and 10 mg tablets, a Janus kinase (JAK) inhibitor, the first in a new class of oral medicines being investigated for the treatment of adult patients with moderate to severe chronic plaque psoriasis who are candidates for systemic therapy or phototherapy.
Sign-up for Pfizer Announces FDA Acceptance For Review Of Supplemental New Drug Application For Oral XELJANZ® (tofacitinib citrate) For Adult Patients With Moderate To Severe Chronic Plaque Psoriasis investment picks
2015/2/3
By Chelsey Dulaney Standard & Poor's Ratings Services on Tuesday cut its credit ratings on several European banks, including Barclays PLC, Credit Suisse Group AG and HSBC Holdings PLC, citing a smaller likelihood of government support under new European Union legislation.
Sign-up for S&P Cuts Ratings on Several European Banks -- Update investment picks
2015/2/3
By Chelsey Dulaney Standard & Poor's Ratings Services on Tuesday cut its ratings on several European banks and their holding companies, including Barclays PLC, Credit Suisse Group AG and HSBC Holdings PLC, citing a smaller likelihood of government support under new European Union legislation.
Sign-up for S&P Cuts Ratings on Several European Banks investment picks
2015/2/9
Trevena, Inc. (NASDAQ: TRVN), a clinical-stage biopharmaceutical company and leader in the discovery and development of G protein coupled receptor (GPCR) biased ligands, today announced positive data from a Phase 1 multiple ascending dose study of TRV734, a novel drug candidate in development as an orally administered treatment for moderate-to-severe acute and chronic pain.
Sign-up for Trevena Announces Positive Results from Phase 1 Multiple Ascending Dose Study of TRV734 for Moderate to Severe Acute and Chronic Pain investment picks
2014/12/15
BOSTON, Dec.
Sign-up for Zafgen Announces Initiation of Phase 2b Trial of Beloranib in Severe Obesity investment picks
2014/12/1
Nuveen Investments, a leading global provider of investment services to institutions, as well as individual investors, today announced that 42 closed-end funds have declared additional cash distributions with the record, ex-dividend, payable and reinvest date outlined below.
Sign-up for Several Nuveen Closed-End Funds Declare Year-End Distributions investment picks
2014/12/1
ROCKVILLE, Md., Dec.
Sign-up for Seven-day event brings together severely injured service members and their families from across the country investment picks
2014/12/10
By Ophir GottliebTwenty-one are in worse shape than Bank of America was at the height of the credit crisis Big banks in Europe are riskier than anywhere else in the world.
Sign-up for UPDATE: European banks are stuck in a severe crisis investment picks
2014/12/12
SAN DIEGO , Dec.
Sign-up for Qualcomm Commits to Invest $40 Million into Several Promising Chinese Companies investment picks
2014/12/11
Expects to complete submission in the first half of 2015 DUBLIN , Dec.
Sign-up for Jazz Pharmaceuticals Initiates Rolling NDA Submission For Defibrotide For The Treatment Of Severe Hepatic Veno-Occlusive Disease investment picks
2014/12/11
First Presentation of Phase 3 Data From Brodalumab Psoriasis Program THOUSAND OAKS, Calif.
Sign-up for Amgen And AstraZeneca To Present Results From Phase 3 AMAGINE-1™ Study Evaluating Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis investment picks
2014/12/15
CAMBRIDGE, Mass., Dec.
Sign-up for Idera Announces Several Key Additions to Management Team investment picks
2014/12/21
Study Meets Primary Endpoint of Reducing the Percentage of Patients with Incident Vertebral Fracture and Also Meets Important Secondary Endpoints: Adverse Events Consistent with Previous Clinical Experience Radius Remains on Track for Completion of the Ongoing 6-Month ACTIVExtend Study and NDA Submission in the Second Half of 2015 Radius' Investigational Drug Abaloparatide Transdermal Program Achieves Key Milestone in its Development as a Post-Approval Line Extension Company to Host Conference Call Tomorrow (Monday, December 22, 2014) at 8:00 a.m. ET WALTHAM, Mass., Dec.
Sign-up for Radius Announces Positive Phase 3 Top-Line Results for Its Investigational Drug Abaloparatide-SC in Postmenopausal Women With Severe Osteoporosis investment picks
2014/12/18
OpSec Security , the global leader in anti-counterfeiting and brand protection, today announced that over the past four months it has been selected to provide online brand protection services to six new accounts across a variety of industries, including fashion and luxury, health and beauty, automotive and consumer goods.
Sign-up for OpSec Security Announces Several New Client Wins investment picks
2015/1/13
BERKELEY HEIGHTS, N.J., Jan.
Sign-up for Authentidate's InscrybeMD Telehealth Solution Expanded to Several Florida Hospital Locations investment picks

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Several Companies
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: Seven Companies  |  Next: Shale Assets